PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Current status of carbon dioxide angiography.

Abstract Unfamiliarity of endovascular surgeons with carbon dioxide (CO2) angiography is one of the main reasons for its limited use. This review is intended to familiarize the reader with the principles and applications of that modality.
PMID
Related Publications

Safety and efficacy of endovascular therapy with a simple homemade carbon dioxide delivery system in patients with ileofemoral artery diseases.

Carbon dioxide in vascular imaging and intervention.

Carbon Dioxide as Contrast Medium to Guide Endovascular Aortic Aneurysm Repair.

The current status of the use of carbon dioxide in diagnostic and interventional angiographic procedures.

Automated Carbon Dioxide Angiography for the Evaluation and Endovascular Treatment of Diabetic Patients With Critical Limb Ischemia.

Authors

Mayor MeshTerms
Keywords
Journal Title journal of vascular surgery
Publication Year Start




PMID- 28735955
OWN - NLM
STAT- MEDLINE
DA  - 20170724
DCOM- 20170731
LR  - 20170731
IS  - 1097-6809 (Electronic)
IS  - 0741-5214 (Linking)
VI  - 66
IP  - 2
DP  - 2017 Aug
TI  - Current status of carbon dioxide angiography.
PG  - 618-637
LID - S0741-5214(17)31131-X [pii]
LID - 10.1016/j.jvs.2017.03.446 [doi]
AB  - OBJECTIVE: Unfamiliarity of endovascular surgeons with carbon dioxide (CO2)
      angiography is one of the main reasons for its limited use. This review is
      intended to familiarize the reader with the principles and applications of that
      modality. METHODS: We conducted a comprehensive review of contemporary literature
      related to CO2 angiography and its use in the field of vascular and endovascular 
      surgery, including technical details and diagnostic and interventional
      applications. RESULTS: Cardinal physicochemical characteristics of CO2 include
      buoyancy, ultralow viscosity, and nonmixing with blood. Because of the risk of
      neurotoxicity, intra-arterial CO2 angiography should only be performed below the 
      diaphragm. Venous CO2 angiography can be performed anywhere in the torso and
      extremities. Ultralow viscosity enables intraprocedural imaging during vascular
      interventions without the need to exchange for an angiographic catheter.
      Benefits, advantages, and emerging applications of CO2 angiography are listed.
      Potential complications and their avoidance and troubleshooting are discussed.
      CONCLUSIONS: CO2 holds promise as an effective and versatile angiographic
      contrast agent. It is also a valuable modality for the guidance of endovascular
      interventions. Current availability of easy to use, safe, and portable CO2
      delivery systems will likely expand the use of that modality even beyond the
      traditional indications of renal insufficiency and iodinated contrast allergy.
CI  - Copyright (c) 2017 Society for Vascular Surgery. Published by Elsevier Inc. All
      rights reserved.
FAU - Sharafuddin, Mel J
AU  - Sharafuddin MJ
AD  - Department of Surgery, The University of Iowa Roy and Lucille Carver College of
      Medicine, Iowa City, Iowa. Electronic address: [email protected]
FAU - Marjan, Anna E
AU  - Marjan AE
AD  - Department of Surgery, The University of Iowa Roy and Lucille Carver College of
      Medicine, Iowa City, Iowa.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - J Vasc Surg
JT  - Journal of vascular surgery
JID - 8407742
RN  - 0 (Contrast Media)
RN  - 142M471B3J (Carbon Dioxide)
SB  - IM
MH  - Angiography/adverse effects/instrumentation/*methods
MH  - Carbon Dioxide/*administration & dosage/adverse effects
MH  - Contrast Media/*administration & dosage/adverse effects
MH  - Endovascular Procedures/adverse effects/instrumentation/*methods
MH  - Equipment Design
MH  - Humans
MH  - Predictive Value of Tests
MH  - Radiography, Interventional/adverse effects/instrumentation/*methods
MH  - Reproducibility of Results
MH  - Risk Factors
MH  - Treatment Outcome
MH  - Vascular Diseases/*diagnostic imaging/*therapy
EDAT- 2017/07/25 06:00
MHDA- 2017/08/02 06:00
CRDT- 2017/07/25 06:00
PHST- 2016/09/28 [received]
PHST- 2017/03/27 [accepted]
AID - S0741-5214(17)31131-X [pii]
AID - 10.1016/j.jvs.2017.03.446 [doi]
PST - ppublish
SO  - J Vasc Surg. 2017 Aug;66(2):618-637. doi: 10.1016/j.jvs.2017.03.446.